Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus

Clinical Infectious Diseases

Volumn 60, Issue 6, 2015, Pages 950-958

  Berenguer, Juan ^a,v   Zamora, Francisco X ^b,c   Aldámiz Echevarría, Teresa ^a   Von Wichmann, Miguel A ^d   Crespo, Manel ^e   López Aldeguer, José ^f   Carrero, Ana ^a   Montes, Marisa ^b,c   Quereda, Carmen ^g   Téllez, María J ^h   Galindo, María J ⁱ   Sanz, José ^j   Santos, Ignacio ^k   Guardiola, Josep M ^l   Barros, Carlos ^m   Ortega, Enrique ⁿ   Pulido, Federico ^o,p   Rubio, Rafael ^o,p   Mallolas, Josep ^q   Tural, Cristina ^r   Jusdado, Juan J ^s   Pérez, Gloria ^t   Díez, Cristina ^a   Álvarez Pellicer, Julio ^b,c   Esteban, Herminia ^u   Bellon J M ^v   González García, Juan ^b,c   Miralles, P ^v   Cosin J ^v   Lopez J C ^v   Padilla, B ^v   Parras, F ^v   Carrero, A ^v   Aldamiz Echevarria T ^v   Tejerina, F ^v   Gutierrez I ^v   Ramirez M ^u,v   Carretero, S ^v   Alvarez Pellicer, J ^b   Rodriguez E ^b   Arribas, J R ^b   Montes, M L ^b   Bernardino, I ^b   Pascual, J F ^b   Zamora, F ^b   Pena J M ^b   Arnalich, F ^b   Diaz M ^b   Gonzalez Garcia J ^b   Bustinduy, M J ^d   Iribarren, J A ^d   Rodriguez Arrondo F ^d   Von Wichmann, M A ^d   Blanes, M ^f   Cuellar, S ^f   Lacruz, J ^f   Montero, M ^f   Salavert, M ^f   Lopez Aldeguer J ^f   Callau, P ^q   Miro J M ^r   Gatell, J M ^q   Ferrer, A ⁱ   Galindo, M J ⁱ   Van Den Eynde, E ^e   Perez M ^e   Ribera, E ^e   Crespo, M ^e   Vergas, J ^h   Tellez M J ^h   Casado, J L ^g   Dronda, F ^g   Moreno, A ^g   Perez Elias M J ^g   Sanfrutos, M A ^g   Moreno, S ^g   Quereda, C ^g   Jou, A ^r   Tural, C ^r   Arranz, A ^j   Casas, E ^j   De Miguel, J ^j   Schroeder, S ^j   Sanz, J ^j,k   Condes E ^m   Barros, C ^m   Santos, I ^k   Hernando, A ^o   Rodriguez V ^o   Rubio, R ^o   Domingo, P ^l   Guardiola, J M ^l   Ortiz, L ⁿ   Ortega, E ⁿ   Torres, R ^s   Cervero, M ^s   Jusdado, J J ^s   Rodriguez Zapata M ^w   Perez G ^t   Gaspar, G ^t   Barquilla, E ^u   Moyano, B ^u   Aznar, E ^u   Esteban, H ^u   more..

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^j HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^k HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^m HOSPITAL DE MÓSTOLES   (Spain)

ⁿ HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^o HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^p Universidad Complutense   (Spain)

^q HOSPITAL CLÍNIC   (Spain)

^r HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^s HOSPITAL SEVERO OCHOA   (Spain)

^t HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^u Fundacion SEIMC GESIDA   (Spain)

^v HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^w HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

more..

Author keywords

Follow up studies; Hepatitis C; HIV; Interferon; Treatment outcome

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL RESEARCH; COHORT ANALYSIS; COMPARATIVE STUDY; DECOMPENSATED LIVER CIRRHOSIS; FEMALE; FIB 4 INDEX; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; BIOPSY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; HEPATITIS C, CHRONIC; HIV INFECTIONS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; PROGNOSIS;

ADULT; BIOPSY; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COINFECTION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; PROGNOSIS; ROC CURVE;

EID: 84936065635     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu939     Document Type: Article

References (27)

1. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009; 49:1017-44.
2. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38:1449-57.
3. Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007; 7:40.
4. Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36(4 pt 1):986-92.
5. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-26.
6. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43:1317-25.
7. Castera L, Bedossa P. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy? Liver Int 2011; 31(suppl 1):13-7.
8. Sanchez-Conde M, Montes-Ramirez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2010; 17:280-6.
9. Nunes D, Fleming C, Offner G, et al. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 2010; 105:1346-53.
10. Fernandez-Montero JV, Barreiro P, Vispo E, Labarga P, Sanchez-Parra C, Soriano V. Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy. AIDS 2013; 27:1129-34.
11. Ngo Y, Munteanu M, Messous D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006; 52:1887-96.
12. Vergniol J, Foucher J, Terrebonne E, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140:1970-9.e3.
13. Chinnaratha MA, Jeffrey GP, Macquillan G, et al. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver Int 2014; 34:720-7.
14. Macias J, Camacho A, Von Wichmann MA, et al. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. AIDS 2013; 27:2541-9.
15. Berenguer J, Alvarez-Pellicer J, Martin PM, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50:407-13.
16. Berenguer J, Rodriguez E, Miralles P, et al. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2012; 55:728-36.
17. Berenguer J, Alvarez-Pellicer J, Carrero A, et al. Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus. J Hepatol 2013; 58:1104-12.
18. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20(1 pt 1):15-20.
19. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-43.
20. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28:1687-95.
21. Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients. J Hepatol 1998; 28:930-8.
22. Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012; 308:370-8.
23. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 2010; 51:1445-9.
24. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43:167-76.
25. Afdhal N, McHutchison J, Brown R, et al. Thrombocytopenia associated with chronic liver disease. J Hepatol 2008; 48:1000-7.
26. Shiffman ML, Diago M, Tran A, et al. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006; 4:645-52.
27. Macias J, Berenguer J, Japon MA, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology 2009; 50:1056-63.